Profits and not improving accessibility matter to Indian drug makers
FICCI conference organised to discuss access to generic medicines focuses more on increasing exports
Delhi High Court scraps ban on 344 fixed combination drugs
Health ministry banned 344 fixed combination drugs in March fearing antimicrobial resistance and other health hazards
Antibiotic residues in wastewater may trigger antimicrobial resistance in India, China: Study
Antimicrobial resistance results in an increase in morbidity, mortality and healthcare costs for the individual, health system and country
Single nanoparticle twists pave the way for medicines on demand: Study
Understanding chirality — twists within nanoparticles — can help several industries, including pharma
Pharma’s dirty deals to stall generics
As generic companies, including Indian firms, collude with innovator pharma giants in pay-for-delay pacts, consumers pay a high price
Remdisivir shows no benefits on COVID-19 patients in first clinical trial
Lancet paper contradicts Gilead results on drug which claimed improvement in patients
Finally, antiviral drug for dengue in the offing
World’s first botanical drug against dengue is in the final stage of development at the Delhi-based International Centre for Genetic …
Government stand against EU ban on Indian drugs much needed, says industry
Standing against the arbitrary ban on 700 drugs, India has decided to defer the proposed talks on the free trade agreement between India and the EU
When generics turn into Big Pharma
Top generics firms, some from India, are charged with price-fixing and sleazy deals; Sun Pharma has paid up to settle claims
AI for drug development: How trustworthy is the tech?
Pharma companies today deploy artificial intelligence with a potential to reduce the drug development cycle by half
D Srinivasa Reddy takes over as Director CSIR-IICT
Reddy will also hold the additional charge of the post of director of CSIR-IIIM, Jammu and director, CSIR-CDRI, Lucknow
Beware of a deal with Trump
As the US president comes visiting to India there is worry about the demands he will make on intellectual property
Software outsmarts drug research
Now, a programme can bypass patented drug pathways and create synthetically-produced medicines
There's an unhealthy alliance between doctors and pharma firms
The government has shown little interest to penalise pharma companies that offer sops to doctors to push their drugs
COVID-19 vaccines for all: Will Sputnik V speed up vaccination in India
Sputnik V’s entry may not dent the ongoing vaccine shortage in India, but its domestic production could change things by year-end
It is critical to view antimicrobial resistance through a multi-dimensional lens
Reducing pollution from the pharmaceutical, agricultural and healthcare sectors is needed to reduce the emergence, transmission and spread of …
India: the pharmacy of the world where ‘crazy drug combinations’ go unregulated
Of 175 drug combinations used to treat pain-relief, diabetes, anxiety/depression, and psychosis, a study found that 115 combinations had no …
'India’s drug dependence on China not good for its health sector'
Setting up of large-scale pharma and chemical clusters in proximity to each other can help sector perform better, says industry body ASSOCHAM
This is how rich nations protect profits of multinational pharma firms
When rich nations insist on patent linkage provisions in bilateral and regional trade pacts, there is a way out
After cough-syrup, now eye drops: India-made solution causes 1 death, several infections in US
This could be particularly damning for India’s drug regulatory system since it is coming on the heels of cough-syrup-associated deaths in …
New hepatitis drug to cost more in middle income nations; activists cry foul
Pharma company’s strategy of different prices for different countries to affect quality treatment of 185 million people infected with …
How dosage of fever drugs has again highlighted nexus of pharma firms, doctors
No regulation on marketing strategies by drug companies has created a medical autocracy, the Dolo-650 controversy shows
Modi Cabinet approves 100% FDI in medical devices sector via automatic route
Existing conditions and prior approval required in case of merger and acquisition done away with
2022 Chemistry Nobel awarded for ‘click chemistry’, which has possible applications in healthcare
Carolyn Bertozzi, Morten Meldal and Barry Sharpless worked on click chemistry, or linking chemicals together, and biorthogonal reactions, …
That which is injurious to health
Book>> Bad Pharma • by Ben Goldacre • Fourth Estate • £13